Medullary thyroid cancer

Also found in: Encyclopedia.

Medullary thyroid cancer (MTC)

A slow-growing tumor associated with MEN.
References in periodicals archive ?
Calcitonin levels are evaluated and the blood is examined to detect the presence of mutations in the RET gene that raise suspicion of medullary thyroid cancer.
Diagnosis in medullary thyroid cancer with [18F]FDGPET and improvement using a combined PET-CT scanner.
Global Markets Direct's, 'Medullary Thyroid Cancer - Pipeline Review, H1 2012', provides an overview of the Medullary Thyroid Cancer therapeutic pipeline.
4,5) Medullary thyroid cancer is a specific form of thyroid cancer that comprises 2-8% of the 50,000 new cases of the disease in the USA and Europe each year.
diameter) Medullary thyroid cancer Invasive or metastatic thyroid cancer Anaplastic (rapidly spreading) thyroid cancer
Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Tests revealed he had medullary thyroid cancer - a rare form of the disease affecting just 10 people in Scotland each year.
The fact that there was no medullary thyroid cancer provided evidence that the man did not have multiple endocrine neoplasia (MEN) type 2a.
As of the June 30, 2012 cut-off, 14 patients with a variety of solid tumors had been enrolled in the study: non-small cell lung cancer (NSCLC) (5), gastrointestinal stromal tumor (4), colorectal cancer (2), medullary thyroid cancer (1), thymic cancer (1), and leiomyosarcoma (1).
In 2014, the company launched its Afirma Malignancy Classifiers for medullary thyroid cancer and BRAF, helping to guide surgical decision-making for patients with thyroid nodules who are already going to surgery.
Executive Director, Medical-Science, AstraZeneca, "This adds to previous data which shows vandetanib to be the first therapy to demonstrate improved efficacy vs placebo in a phase III trial in patients with advanced medullary thyroid cancer.
practice patterns for medullary thyroid cancer therapy.